(NASDAQ:SKYX), SKYX Revenues Increased for 7 Consecutive Comparable Quarters from Q1 2024 Through Q3 2025 with $19M in Q1/24, $21M in Q2/24, $22M in Q3/24, $23M in Q4/24, $20M in Q1/25, $23M in Q2/25 and $24M in Q3/25 Gross Profit Improvement by 8% to $8.0 million in the Third Quarter of 2025 Sequentially from $7 […]
(NASDAQ:DFDV), BOCA RATON, FL, Nov. 12, 2025 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today released its 3Q 2025 Shareholder Letter and Business Update. To read the full update, please visit: https://defidevcorp.com/investor?tab=earnings.
(Other OTC:GLASF),(OTC US:GLASF),(Pinksheets:GHBWF),(PinkSheets:GHBWF),(Neo:GLAS-A.NE),(Neo:GLAS-WT.NE), Third quarter results reflect temporary planned scaled back in new planting and wholesale production Company remains on track to return to full production at existing greenhouses in the first quarter of 2026, by year-end 2025 will have the most cannabis acreage planted in the Company's history Previously announced $95 per pound of
(NASDAQ:WRAP), MIAMI, Nov. 12, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a global leader in non-lethal response and public-safety technology solutions, today announced financial and operating results for the third quarter ended September 30, 2025. Highlights of Financial Results: Revenue Growth:Total gross revenue for the three months ended September
(NASDAQ:BRTX), MELVILLE, N.Y., Nov. 12, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today reported financial results for the third quarter ended September 30, 2025 and provided an update on its business. “As energized as we are by the
(NASDAQ:BOLT), Initial clinical data for BDC-4182 Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment
(NASDAQ:MYRG), THORNTON, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR Group”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced it will attend the Bernstein Insights: 4th Annual Industrials Forum investor conference. MYR Group's Chief
(NASDAQ:MXCT),(LSE:MXCT),(LSE:MXCN), ROCKVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced its third quarter ended September 30, 2025 financial results and reiterated its 2025 guidance. Third Quarter and Recent Highlights Core
(NASDAQ:EGAN), SUNNYVALE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — eGain (Nasdaq: EGAN), an AI CX automation platform provider, today announced financial results for its fiscal 2026 first quarter ended September 30, 2025. “I am pleased with our strong start to the fiscal year, highlighted by 23% year-over-year ARR growth in AI Knowledge Hub, and a
(NASDAQ:ULY), ASHBURN, Va., Nov. 12, 2025 (GLOBE NEWSWIRE) — Urgent.ly Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the third quarter ended September 30, 2025. “We're pleased to report continued progress in our financial performance. Revenue grew quarter-over-quarter, demonstrating early signs